Albemarle is the latest big firm to sell its catalyst businesses, with deals totaling $660 million.
The chemical firm has agreed to two separate transactions:
The divestiture includes two separate transactions.
Ketjen is the catalyst business that Albemarle spun off as a wholly owned subsidiary in 2024.
Author's summary: Albemarle sells catalyst businesses for $660 million.